Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin heavy chain like 18, pseudogene (FTHL18P) is a processed pseudogene in the human genome and part of the ferritin multigene family, which consists of the primary ferritin heavy chain gene (FTH1), several related protein-coding genes, and over 40 pseudogenes[3][4][6]. Pseudogenes such as FTHL18P do not encode a functional protein due to disruptions in their coding sequence and generally lack significant biological function; however, some ferritin pseudogenes have been described to exert gene regulatory activity by acting as competing endogenous RNAs that modulate the expression of their parental gene (FTH1) via microRNA binding[6][7]. There is currently no evidence that FTHL18P itself is expressed as RNA or exerts any such regulatory function, in contrast to a few other ferritin heavy chain pseudogenes[3][4][6]. FTHL18P is not a therapeutic drug target or biomarker, is not linked to any known disease, and has no known protein or physiological activity in humans[3][4][6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin heavy chain like 18, pseudogene (FTHL18P).